Insights

Innovative AI Platform Causaly offers a cutting-edge AI platform that accelerates biomedical research and drug discovery, making it an attractive partner for organizations seeking to enhance their R&D capabilities with advanced technology.

Recent Product Launches The company has recently introduced new AI-powered tools such as Causaly Agentic Research and Pipeline Graph, indicating increasing market traction and ongoing innovation that could be leveraged for targeted sales strategies.

Strong Funding Backing Causaly secured $60 million in Series B funding from prominent investors, demonstrating strong financial support and growth potential, which signals a solid opportunity for enterprise partnerships and scaled collaborations.

Market Focus With a focus on life science research and biomedicine, Causaly’s solutions are ideal for pharmaceutical companies, biotech firms, and research institutions aiming to improve data analysis and decision-making processes.

Technology Stack Compatibility The use of advanced tech such as Neo4j, MLflow, and GraphQL indicates Causaly’s platform is built on modern, scalable infrastructure, aligning well with clients seeking innovative, reliable AI-driven data solutions.

Similar companies to Causaly

Causaly Tech Stack

Causaly uses 8 technology products and services including XML, Neo4j, MLflow, and more. Explore Causaly's tech stack below.

XML
Data Management
Neo4j
Database
MLflow
Development
GitLab
Issue Trackers
HubSpot Chat
Live Chat
TypeScript
Programming Languages
GraphQL
Programming Languages
Datadog
Real User Monitoring

Media & News

Causaly's Email Address Formats

Causaly uses at least 1 format(s):

Causaly Email Formats	Example	Percentage
First.Last@causaly.com	John.Doe@causaly.com	75%
First.L@causaly.com	John.D@causaly.com	20%
F.Last@causaly.com	J.Doe@causaly.com	4%
First.Middle@causaly.com	John.Michael@causaly.com	1%

Frequently Asked Questions

Where is Causaly's headquarters located?

Causaly's main headquarters is located at 10-16 Elm Street London, England wc1x 0bj United Kingdom. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is Causaly's official website and social media links?

Causaly's official website is causaly.com and has social profiles on LinkedIn.

What is Causaly's NAICS code?

Causaly's NAICS code is 5112 - Software Publishers.

How many employees does Causaly have currently?

As of April 2026, Causaly has approximately 133 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operating Officer: M. C.Chief Product Officer: S. B.Vp And Partner, Strategy And Growth: S. M.. Explore Causaly's employee directory with LeadIQ.

What industry does Causaly belong to?

Causaly operates in the Software Development industry.

What technology does Causaly use?

Causaly's tech stack includes XMLNeo4jMLflowGitLabHubSpot ChatTypeScriptGraphQLDatadog.

What is Causaly's email format?

Causaly's email format typically follows the pattern of First.Last@causaly.com. Find more Causaly email formats with LeadIQ.

When was Causaly founded?

Causaly was founded in 2018.

Causaly

Q: What is Causaly's official website and social media links?

Causaly's official website is causaly.com. Causaly has social profiles on LinkedIn.

Q: How many employees does Causaly have currently?

Causaly has approximately 133 employees.

Q: What technology does Causaly use?

Causaly's tech stack includes HSTS, Neo4j, Vimeo, Datadog, Call Dynamics.

Q: What is Causaly's NAICS code?

Causaly's NAICS code is 5112 (Software Publishers).

Software DevelopmentEngland, United Kingdom51-200 Employees

Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. 

Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.